Arthur M. Cohen & Associates LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 23.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,041 shares of the healthcare conglomerate’s stock after selling 639 shares during the quarter. Arthur M. Cohen & Associates LLC’s holdings in UnitedHealth Group were worth $1,069,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of UnitedHealth Group by 20.8% during the 1st quarter. Thurston Springer Miller Herd & Titak Inc. now owns 4,976 shares of the healthcare conglomerate’s stock worth $2,606,000 after buying an additional 858 shares during the last quarter. Lake Street Private Wealth LLC grew its position in UnitedHealth Group by 257.8% during the first quarter. Lake Street Private Wealth LLC now owns 5,084 shares of the healthcare conglomerate’s stock valued at $2,663,000 after acquiring an additional 3,663 shares during the period. Eclectic Associates Inc. ADV lifted its stake in shares of UnitedHealth Group by 1.3% in the 1st quarter. Eclectic Associates Inc. ADV now owns 9,929 shares of the healthcare conglomerate’s stock valued at $5,199,000 after purchasing an additional 131 shares in the last quarter. Lmcg Investments LLC increased its position in UnitedHealth Group by 1.9% during the 1st quarter. Lmcg Investments LLC now owns 38,708 shares of the healthcare conglomerate’s stock worth $20,273,000 after purchasing an additional 734 shares in the last quarter. Finally, Fermata Advisors LLC raised its holdings in UnitedHealth Group by 9.0% in the first quarter. Fermata Advisors LLC now owns 1,483 shares of the healthcare conglomerate’s stock valued at $777,000 after buying an additional 123 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Insider Activity
In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction dated Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by insiders.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the firm earned $6.91 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
Analysts Set New Price Targets
UNH has been the subject of several recent research reports. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday. Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Bank of America downgraded UnitedHealth Group from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. TD Securities restated a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, Robert W. Baird dropped their price objective on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $428.43.
Get Our Latest Stock Analysis on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Where Do I Find 52-Week Highs and Lows?
- Alphabet Stock Analysis: What’s Next—Bull or Bear Market?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Utilities Stocks With Big Earnings, Balanced Risk
- Stock Dividend Cuts Happen Are You Ready?
- NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.